We are thrilled to announce that we are part of the European Microbiome Innovation for Health (EMIH).
EMIH) is a European non-profit association that promotes innovation in microbiome-based therapies and diagnostics.
EMIH, an organisation founded in 2024 as an evolution of the French APM Alliance, promotes the microbiota as a public health priority in the EU and seeks to position Europe as a global leader, ensuring equitable access for patients and a robust regulatory environment. Joining this coalition positions us as a disruptive and innovative company in the development of microbiota-based therapies and allows us to accelerate the arrival of microbiotic solutions in the clinic.
The association is growing stronger, having added 13 new members in 2025, and is consolidating its role as a benchmark platform. This significantly strengthens our ability to influence policies and regulatory frameworks, while expanding our networking opportunities and access to specialised capital.
Being part of EMIH allows us to join forces with other companies, institutions and healthcare entities with a common vision: to position Europe as a global leader in this emerging field.
We continue to move forward, convinced that the microbiota will be one of the great answers to the health challenges of the present and the future.
More information: europeanmicrobiome.org
